Graft survival.
Brundin
P
P
Petersén
A
A
Hansson
O
O
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D016380:Brain Tissue Transplantation / Q000379:methods*; D002839:Chromans / Q000627:therapeutic use; D015925:Cryopreservation; D016332:Fetal Tissue Transplantation; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006085:Graft Survival; D009414:Nerve Growth Factors / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000627:therapeutic use; D009474:Neurons / Q000637:transplantation; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D051381:Rats; D011954:Receptors, Dopamine; D013378:Substantia Nigra / Q000196:embryology / Q000637:transplantation; D014021:Tissue Preservation; D014022:Tissue Survival
D000975:Antioxidants; D002839:Chromans; C495041:Gdnf protein, rat; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D010879:Piperazines; D011954:Receptors, Dopamine; C066382:U 78517F